15. Lane HC, Zunich KM, Wilson W, et al: Syngeneic bone marrow transplantation and adoptive 
transfer of peripheral blood lymphocytes combined with zidovudine in human immunodeficiency virus 
(HIV) infection. Ann Intern Med 113:512-519, 1990. 
16. Reddehase MJ, Weiland F, Munch K, et al: Interstitial murine CMV pneumonia after irradiation: 
Characterization of cells that limit viral replication during established infection of the lungs. J Virol 
55:264-273, 1985. 
17. Adas GL, Jones PD: The immune response to influenza infection. Curr Top Microbiol Immunol 
128:1-54, 1984. 
18. Lin YL, Askonsas BA: Biological properties of an influenza A-virus-specific killer T cell clone. J 
Exp Med 154:225-234, 1981. 
19. Lukacher AE, Braciale VL, Braciale TF: In vivo effector function of influenza virus-specific T 
lymphocyte clones is highly specific. J Exp Med 160:814-823, 1984. 
20. Walker BD, Chakrabarti S, Moss B, et al: HIV-specific cytotoxic T lymphocytes in seropositive 
individuals. Nature 328:345, 1987. 
21. Langlade-Demoyen P, Michel F, Hoffenbach A, et al: Immune recognition of AIDS virus antigens 
by human and murine cytotoxic T lymphocytes. J Immunol 141:1949, 1988. 
22. Riviere Y, Tanneau-Slavadori F, Regnault A, et al: Human immunodeficiency virus-specific 
cytotoxic responses of seropositive individuals: Distinct types of effector cells mediate killing of 
targets expressing gag and env proteins. J Virol 63:2270, 1989. 
23. Walker BD, Flexner C, Paradis TJ, et al: HIV-1 reverse transcriptase is a target for cytotoxic T 
lymphocytes in infected individuals. Science 240:64, 1988. 
24. Hosmalin A, Clerici M, Houghten R, et al: An epitope in human immunodeficiency virus 1 reverse 
transcriptase recognized by both mouse and human cytotoxic T lymphocytes. Proc Natl Acad Sci 
USA 87:2344, 1990. 
25. Culmann B, Gomard E, Kieny M-P, et al: An antigen peptide of the HIV-1 NEF protein recognized 
by cytotoxic T lymphocytes of seropositive individuals in association with different HLA-B molecules. 
Eur J Immunol 19:2383, 1989. 
26. McChesney M, Tanneau F, Regnault A, et al: Detection of primary cytotoxic T lymphocytes specific 
for the envelope glycoprotein of HIV-1 by deletion of env amino-terminal signal sequence. Eur J 
Immunol 20:215, 1990. 
27. Borysiewicz L, Morris S, Page J, et al: Human cytomegalovirus-specific cytotoxic T lymphocytes: 
Requirements for in vitro generation and specificity. Eur J Immunol 13:804-809, 1983. 
28. Crawford DH, Iliescu V, Edwards AJ, et al: Characterization of Epstein-Barr virus-specific T cells 
from the peripheral blood of seropositive individuals. Br J Cancer 47:681, 1983. 
29. Pantaleo G, Koenig S, Baseler M, et al: Defective clonogenic potential of CD8 + lymphocytes in 
patients with AIDS: Expansion in vivo of a nonclonogenic CD3 + CD8 + DR + CD25' T cell 
population. J Immunol 144:1696-1704, 1990. 
30. Walker BD, Plata F: Cytotoxic T lymphocytes against HIV. AIDS 4:177-184, 1990. 
31. Fauci AS, Schnittman SM, Poli G, et al: Immunopathogenic mechanisms in human 
immunodeficiency virus (HIV) infection. Ann Intern Med 114:678-693, 1991. 
32. Greenberg PD: Adoptive T cell therapy of tumors: Mechanisms operative in the recognition and 
elimination of tumor cells. F. Dixon (ed.): Adv Immunol. Orlando, FL, Academic Press, 1991, pp 
281-355. 
33. Grimm EA, Mazumder A, Zhang HA, et al: LAK cell phenomenon: Lysis of natural killer-resistant 
fresh solid tumor cells by interleukin-2-activated autologous human peripheral blood lymphocytes. J 
Exp Med 155:1823-1841, 1982. 
34. Sondel PM, Hank JA, Kohler PC, et al: Destruction of human lymphocytes by IL-2-activated 
cytotoxic cells. J Immunol 137:502-511, 1986. 
Recombinant DNA Research, Volume 15 
[631] 
